Kawakami Y - Search Results

1

RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer.

Yamamoto Y, Shimada S, Akiyama Y, Tsukihara S, Sugimoto R, Kabashima A, Tokunaga M, Kinugasa Y, Kawakami Y, Tanaka S. Yamamoto Y, et al. Among authors: kawakami y. J Gastroenterol. 2023 Jun;58(6):540-553. doi: 10.1007/s00535-023-01969-w. Epub 2023 Mar 2. J Gastroenterol. 2023. PMID: 36859628

2

Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells.

Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H, Izumiya M, Sakai G, Adachi M, Funakoshi S, Nakamura S, Hamamoto Y, Kanai T, Takaishi H, Kawakami Y, Hibi T. Akagi H, et al. Among authors: kawakami y. Gastric Cancer. 2013 Jan;16(1):100-10. doi: 10.1007/s10120-012-0153-6. Epub 2012 Apr 24. Gastric Cancer. 2013. PMID: 22527182

3

Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura.

Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Kajihara M, et al. Among authors: kawakami y. J Gastroenterol Hepatol. 2007 Jan;22(1):112-8. doi: 10.1111/j.1440-1746.2006.04359.x. J Gastroenterol Hepatol. 2007. PMID: 17201890

4

[Cancer immunotherapy by immuno-checkpoint blockade].

Kawakami Y. Kawakami Y. Rinsho Ketsueki. 2015 Oct;56(10):2186-94. doi: 10.11406/rinketsu.56.2186. Rinsho Ketsueki. 2015. PMID: 26458459 Japanese.

5

Inter-patient and Intra-tumor Heterogeneity in the Sensitivity to Tumor-targeted Immunity in Colorectal Cancer.

Miyauchi T, Yaguchi T, Kawakami Y. Miyauchi T, et al. Among authors: kawakami y. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):54-59. doi: 10.2177/jsci.40.54. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 28539555 Free article. Review.

6

Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.

Kato D, Yaguchi T, Iwata T, Morii K, Nakagawa T, Nishimura R, Kawakami Y. Kato D, et al. Among authors: kawakami y. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):68-77. doi: 10.2177/jsci.40.68. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 28539557 Free article. Review.

7

Immune-resistant mechanisms in cancer immunotherapy.

Kawakami Y, Ohta S, Sayem MA, Tsukamoto N, Yaguchi T. Kawakami Y, et al. Int J Clin Oncol. 2020 May;25(5):810-817. doi: 10.1007/s10147-019-01611-x. Epub 2020 Jan 9. Int J Clin Oncol. 2020. PMID: 31919690 Review.

8

Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3.

Hayakawa T, Yaguchi T, Kawakami Y. Hayakawa T, et al. Among authors: kawakami y. Cancer Sci. 2020 Dec;111(12):4326-4335. doi: 10.1111/cas.14675. Epub 2020 Oct 20. Cancer Sci. 2020. PMID: 33006786 Free PMC article.

9

Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.

Kinoshita T, Sayem MA, Yaguchi T, Kharma B, Morii K, Kato D, Ohta S, Mashima Y, Asamura H, Kawakami Y. Kinoshita T, et al. Among authors: kawakami y. Cancer Sci. 2021 Apr;112(4):1390-1401. doi: 10.1111/cas.14812. Epub 2021 Mar 18. Cancer Sci. 2021. PMID: 33453147 Free PMC article.

10

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, Noji S, Yaguchi T, Iwata T, Ohta S, Fujita T, Tanosaki R, Handa M, Okamoto S, Amagai M, Kawakami Y. Hirai I, et al. Among authors: kawakami y. Cancer Sci. 2021 Aug;112(8):3163-3172. doi: 10.1111/cas.15009. Epub 2021 Jun 30. Cancer Sci. 2021. PMID: 34101300 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,801 results

Search Page